000 | 01975 a2200541 4500 | ||
---|---|---|---|
005 | 20250514201509.0 | ||
264 | 0 | _c20041102 | |
008 | 200411s 0 0 eng d | ||
022 | _a0022-5347 | ||
024 | 7 |
_a10.1097/01.ju.0000137910.38441.8a _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCzito, Brian | |
245 | 0 | 0 |
_aAdjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. _h[electronic resource] |
260 |
_bThe Journal of urology _cOct 2004 |
||
300 |
_a1271-5 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aActuarial Analysis |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdrug therapy |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aKidney Pelvis _xpathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Metastasis _xpathology |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xpathology |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNeoplasm, Residual _xdrug therapy |
650 | 0 | 4 | _aOutcome and Process Assessment, Health Care |
650 | 0 | 4 |
_aRadiation-Sensitizing Agents _xtherapeutic use |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aUreter _xpathology |
650 | 0 | 4 |
_aUreteral Neoplasms _xdrug therapy |
700 | 1 | _aZietman, Anthony | |
700 | 1 | _aKaufman, Donald | |
700 | 1 | _aSkowronski, Uri | |
700 | 1 | _aShipley, William | |
773 | 0 |
_tThe Journal of urology _gvol. 172 _gno. 4 Pt 1 _gp. 1271-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.ju.0000137910.38441.8a _zAvailable from publisher's website |
999 |
_c15065784 _d15065784 |